Skip to content
Review Open access

Aspirin-Based Thromboprophylaxis Versus Anticoagulant Regimens After Total Hip or Knee Arthroplasty: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials

Oct 2026 · Medicina · Vol 62, pp. 2030 · 0 citations · 32 references
Medicine

TL;DR

The main pooled analyses associated aspirin-based thromboprophylaxis with higher risks of symptomatic thromboembolic events, however, the symptomatic DVT and symptomatic VTE associations were no longer statistically significant after exclusion of CRISTAL or restriction to trials at low risk of bias.

Abstract

Background and Objectives: Aspirin is widely used for venous thromboembolism prophylaxis after total hip arthroplasty (THA) and total knee arthroplasty (TKA); however, uncertainty remains regarding its efficacy and safety compared with anticoagulant regimens. This systematic review and meta-analysis evaluated aspirin-based thromboprophylaxis versus anticoagulant regimens following THA or TKA. Materials and Methods: PubMed, Scopus, Web of Science, and the Cochrane Central Register of Controlled Trials (CENTRAL) were searched through July 2026 for randomized controlled trials comparing aspirin-based prophylaxis with anticoagulant regimens. The primary outcomes were any deep vein thrombosis (DVT), symptomatic DVT, and symptomatic venous thromboembolism (VTE). Secondary outcomes included pulmonary embolism (PE), proximal and distal DVT, bleeding outcomes, wound complications, blood transfusion, and mortality. Risk ratios (RRs) with 95% confidence intervals (CIs) were pooled using random-effects models. Additional risk-difference sensitivity analyses incorporated CRISTAL’s published cluster-adjusted estimates. Results: Sixteen trials involving 21,265 participants were included. Aspirin was associated with higher risks of symptomatic DVT (RR 1.79, 95% CI 1.35–2.38), symptomatic VTE (RR 1.70, 95% CI 1.33–2.18), PE (RR 1.89, 95% CI 1.33–2.68), and distal DVT (RR 1.47, 95% CI 1.06–2.06). Aspirin was associated with lower risks of minor bleeding (RR 0.47, 95% CI 0.31–0.71) and ecchymosis or bruising (RR 0.60, 95% CI 0.39–0.93). No statistically significant differences were detected for the other assessed outcomes. Additional analyses incorporating CRISTAL’s cluster-adjusted risk differences did not identify statistically significant differences for the three primary outcomes or PE. Conclusions: The main pooled analyses associated aspirin-based thromboprophylaxis with higher risks of symptomatic thromboembolic events. However, the symptomatic DVT and symptomatic VTE associations were no longer statistically significant after exclusion of CRISTAL or restriction to trials at low risk of bias. The low-risk analysis identified a significantly higher risk of any DVT with aspirin. Aspirin reduced minor bleeding and bruising without a statistically significant reduction in major or clinically relevant non-major bleeding. These findings require cautious interpretation given dependence on CRISTAL, sensitivity to trial inclusion and analytical approach, and differences in prophylactic strategies and outcome definitions.

Read PDF

Similar papers

Meta-analysis Nov 2026

A comparison of the efficacy and safety of direct oral anticoagulants with low molecular weight heparin for venous thromboembolism prophylaxis after total hip arthroplasty : a systematic review and meta-analysis.

DOACs reduce the risk of VTE and DVT following elective THA compared with LMWH without increasing bleeding risk, for UK-licensed agents and doses.

H. Mohammad, Azmi Rahman, I. Muhammad et al. · 0 citations
Nov 2026

Prevention of Venous Thromboembolism after Total Hip or Knee Replacement.

BACKGROUND Studies comparing aspirin with anticoagulants for venous thromboembolism (VTE) prophylaxis after total hip or knee arthroplasty have had conflicting results. METHODS In a comparative-effectiveness noninferiority trial, we randomly assigned patients undergoing elective hip or knee arthroplasty to receive as...

V. D. Pellegrini, Carol A. Lambourne, L. Magder et al. · 0 citations
Sep 2026

DELAYED ADMINISTRATION OF DIRECT ORAL ANTICOAGULANTS REDUCES TRANSFUSION RISK WHILE NOT INCREASING VENOUS THROMBOEMBOLISM RISK FOLLOWING REVISION TOTAL KNEE ARTHROPLASTY

Direct oral anticoagulants (DOACs) such as apixaban and rivaroxaban are effective prophylactic agents for preventing venous thromboembolism (VTE) following revision total knee arthroplasty (rTKA). However, the optimal timing for postoperative initiation of these agents is unclear. We sought to compare postoperative...

Pranit Kumaran, Matthew A. Lim, Sahil S. Telang et al. · 0 citations
Review Nov 2026

Abstract 6864: Reduced Dose versus Full Dose Direct Oral Anticoagulants for Extended Treatment of Venous Thromboembolism: A Systematic Review and Meta Analysis

Background: Patients with venous thromboembolism (VTE) who complete initial anticoagulation often require extended therapy to prevent recurrence, but this must be balanced against bleeding risks. While reduced-dose direct oral anticoagulants (DOACs) are increasingly used, their comparative efficacy and safety versus...

Abdulmohimen Elkhadar, A. Msherghi · 0 citations
Review Open access Jan 2026

Oral Anticoagulant Monotherapy vs. Combination Therapy in Chronic Coronary Syndrome Requiring Long-Term Anticoagulation: An Updated Meta-Analysis of Randomized Controlled Trials.

IntroductionEvidence surrounding the optimal antithrombotic regimen for patients with chronic coronary syndrome (CCS) requiring oral anticoagulation remains scarce. This meta-analysis evaluates the efficacy and safety of oral anticoagulant (OAC) monotherapy compared to OAC plus single antiplatelet therapy (SAPT) in thi...

Mahwish Sarwar, S. Daniyal, Amna Noor et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.